{"doi":"10.1093/neuonc/noad128","title":"EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression","abstract":"BACKGROUND: Medulloblastoma is the most common pediatric brain malignancy. Patients with the Group 3 subtype of medulloblastoma (MB) often exhibit MYC amplification and/or overexpression and have the poorest prognosis. While Group 3 MB is known to be highly dependent on MYC, direct targeting of MYC remains elusive. METHODS: Patient gene expression data were used to identify highly expressed EYA2 in Group 3 MB samples, assess the correlation between EYA2 and MYC, and examine patient survival. Genetic and pharmacological studies were performed on EYA2 in Group 3 derived MB cell models to assess MYC regulation and viability in vitro and in vivo. RESULTS: EYA2 is more highly expressed in Group 3 MB than other MB subgroups and is essential for Group 3 MB growth in vitro and in vivo. EYA2 regulates MYC expression and protein stability in Group 3 MB, resulting in global alterations of MYC transcription. Inhibition of EYA2 tyrosine phosphatase activity, using a novel small molecule inhibitor (NCGC00249987, or 9987), significantly decreases Group 3 MB MYC expression in both flank and intracranial growth in vivo. Human MB RNA-seq data show that EYA2 and MYC are significantly positively correlated, high EYA2 expression is significantly associated with a MYC transcriptional signature, and patients with high EYA2 and MYC expression have worse prognoses than those that do not express both genes at high levels. CONCLUSIONS: Our data demonstrate that EYA2 is a critical regulator of MYC in Group 3 MB and suggest a novel therapeutic avenue to target this highly lethal disease.","journal":"Neuro-Oncology","year":2023,"id":348161,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":11,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9464,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1087253,"name":"Melanie Y. Vincent","orcid":null,"position":1,"is_corresponding":false},{"id":1090911,"name":"Taylor Hotz","orcid":null,"position":2,"is_corresponding":false},{"id":474837,"name":"Stephen C. Purdy","orcid":"0000-0001-9640-5501","position":3,"is_corresponding":false},{"id":292747,"name":"Sheera R. Rosenbaum","orcid":"0000-0002-7917-2969","position":4,"is_corresponding":false},{"id":288136,"name":"Connor J. Hughes","orcid":"0000-0001-6295-8167","position":5,"is_corresponding":false},{"id":288137,"name":"Jessica Y. Hsu","orcid":"0000-0003-0817-9132","position":6,"is_corresponding":false},{"id":51553,"name":"Michael Oliphant","orcid":null,"position":7,"is_corresponding":false},{"id":1090410,"name":"Brock Armstrong","orcid":"0009-0008-4490-0824","position":8,"is_corresponding":false},{"id":814246,"name":"Veronica M. Wessells","orcid":"0000-0001-9678-8848","position":9,"is_corresponding":false},{"id":756924,"name":"Marileila Varella‐Garcia","orcid":"0000-0002-2310-5863","position":10,"is_corresponding":false},{"id":353882,"name":"Matthew D. Galbraith","orcid":"0000-0003-0485-3927","position":11,"is_corresponding":false},{"id":132342,"name":"Angela M. Pierce","orcid":"0000-0003-0848-0494","position":12,"is_corresponding":false},{"id":1090411,"name":"Dong Wang","orcid":"0000-0002-7652-1692","position":13,"is_corresponding":false},{"id":281451,"name":"Sujatha Venkataraman","orcid":"0000-0002-1512-284X","position":14,"is_corresponding":false},{"id":310928,"name":"Etienne Danis","orcid":"0000-0002-5651-8111","position":15,"is_corresponding":false},{"id":563818,"name":"Bethany Veo","orcid":null,"position":16,"is_corresponding":false},{"id":132345,"name":"Natalie J. Serkova","orcid":"0000-0002-4573-3895","position":17,"is_corresponding":false},{"id":313603,"name":"Joaquı́n M. Espinosa","orcid":"0000-0001-9048-1941","position":18,"is_corresponding":false},{"id":353887,"name":"Daniel L. Gustafson","orcid":"0000-0002-3063-1669","position":19,"is_corresponding":false},{"id":132347,"name":"Rajeev Vibhakar","orcid":"0000-0002-5949-3896","position":20,"is_corresponding":false},{"id":288139,"name":"Heide L. Ford","orcid":"0000-0002-2860-9841","position":21,"is_corresponding":false},{"id":717068,"name":"Arthur Wolin","orcid":"0000-0003-1881-390X","position":0,"is_corresponding":true}],"reference_count":57,"raw_metadata":null,"created_at":"2026-07-19T01:12:06.040073Z","pmid":"37486991","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}